Adverse reactions to zolpidem: Case reports and a review of the literature

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 12, Issue 6, 2010, Pages

  Inagaki, Takuji ^a   Miyaoka, Tsuyoshi ^a   Tsuji, Seiichi ^c   Inami, Yasushi ^b   Nishida, Akira ^d   Horiguchi, Jun ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b N   (Japan)

^c Tsuji Clinic   (Japan)

^d Kaisei Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; PAROXETINE; PAXEVA; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; ZOLPIDEM; ZOLPIDEM TARTRATE;

ADOLESCENT; AMNESIA; ANTEROGRADE AMNESIA; BEDTIME DOSAGE; CASE REPORT; COMPULSION; CONFUSION; DELIRIUM; DEPRESSION; DIZZINESS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG EXCRETION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG WITHDRAWAL; EATING DISORDER; FEMALE; HALLUCINATION; HUMAN; ILLUSION; INSOMNIA; NOCTURNAL EATING; REVIEW; SENSORY DYSFUNCTION; SLEEP WALKING; SOCIAL PHOBIA; SOMNOLENCE; VISUAL HALLUCINATION;

EID: 79251482736     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.09r00849bro     Document Type: Review

References (47)

1. Drover DR. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone. Clin Pharmacokinet. 2004;43(4):227-238
2. Lieberman JA III. Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care. Prim Care Companion J Clin Psychiatry. 2007;9(1):25-31.
3. Salvà P, Costa J. Clinical pharmacokinetics and pharmacodynamics of zolpidem: therapeutic implications. Clin Pharmacokinet. 1995;29(3):142-153.
4. Toner LC, Tsambiras BM, Catalano G, et al. Central nervous system side effects associated with zolpidem treatment. Clin Neuropharmacol. 2000;23(1):54-58.
5. Harrison NL. Mechanisms of sleep induction by GABA(A) receptor agonists. J Clin Psychiatry. 2007;68(suppl 5):6-12.
6. Ozone M, Yagi T, Itoh H, et al. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo. Pharmacopsychiatry. 2008;41(3):106-114.
7. Hajak G, Müller WE, Wittchen HU, et al. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction. 2003;98(10):1371-1378.
8. Ansseau M, Pitchot W, Hansenne M, et al. Psychotic reactions to zolpidem. Lancet. 1992;339(8796):809.
9. Iruela L, Ibañez-Rojo V, Baca E. Zolpidem-induced macropsia in anorexic woman. Lancet. 1993;342(8868):443-444.
10. Katz SE. Possible paroxetine-zolpidem interaction. Am J Psychiatry. 1995;152(11):1689.
11. Pies RW. Dose-related sensory distortions with zolpidem. J Clin Psychiatry. 1995;56(1):35-36.
12. Markowitz JS, Brewerton TD. Zolpidem-induced psychosis. Ann Clin Psychiatry. 1996;8(2):89-91.
13. van Puijenbroek EP, Egberts ACG, Krom HJ. Visual hallucinations and amnesia associated with the use of zolpidem. Int J Clin Pharmacol Ther. 1996;34(7):318.
14. Canaday BR. Amnesia possibly associated with zolpidem administration. Pharmacotherapy. 1996;16(4):687-689.
15. Elko CJ, Burgess JL, Robertson WO. Zolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interaction. J Toxicol Clin Toxicol. 1998;36(3):195-203.
16. Huang C-L, Chang C-J, Hung C-F, et al. Zolpidem-induced distortion in visual perception. Ann Pharmacother. 2003;37(5):683-686.
17. Kito S, Koga Y. Visual hallucinations and amnesia associated with zolpidem triggered by fluvoxamine: a possible interaction. Int Psychogeriatr. 2006;18(4):749-751.
18. de Haas S, Dingemanse J, Hoever P, et al. Pseudohallucinations after zolpidem intake: a case report. J Clin Psychopharmacol. 2007;27(6):728-730.
19. Markowitz JS, Rames LJ, Reeves N, et al. Zolpidem and hallucinations. Ann Emerg Med. 1997;29(2):300-301.
20. Inami K, Miyaoka T, Horiguchi J. Visual hallucination and amnesia after SSRI and zolpidem taking. Clinical Psychiatry. 2004;46:985-987.
21. Brodeur MR, Stirling AL. Delirium associated with zolpidem. Ann Pharmacother. 2001;35(12):1562-1564.
22. Von Moltke LL, Greenblatt DJ, Granda BW, et al. Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations. Br J Clin Pharmacol. 1999;48(1):89-97.
23. Coleman DE, Ota K. Hallucinations with zolpidem and fluoxetine in an impaired driver. J Forensic Sci. 2004;49(2):392-393.
24. Hemeryck A, Belpaire FM. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Curr Drug Metab. 2002;3(1):13-37.
25. Praplan-Pahud J, Forster A, Gamulin Z, et al. Preoperative sedation before regional anaesthesia: comparison between zolpidem, midazolam and placebo. Br J Anaesth. 1990;64(6):670-674.
26. Lebraut C, Chauvin M, Brusset A, et al. Prospective sedation with zolpidem, lorazepam and placebo: a random double blind comparison. Anesthesiology. 1989;71:300.
27. Tsai M-J, Tsai Y-H, Huang Y-B. Compulsive activity and anterograde amnesia after zolpidem use. Clin Toxicol (Phila). 2007;45(2):179-181.
28. Tsai J-H, Yang P, Chen C-C, et al. Zolpidem-induced amnesia and somnambulism: rare occurrences? Eur Neuropsychopharmacol. 2009;19(1):74-76.
29. Yang W, Dollear M, Muthukrishnan SR. One rare side effect of zolpidem-sleepwalking: a case report. Arch Phys Med Rehabil. 2005;86(6):1265-1266.
30. Mendelson WB. Sleepwalking associated with zolpidem. J Clin Psychopharmacol. 1994;14(2):150.
31. Harazin J, Berigan TR. Zolpidem tartrate and somnambulism. Mil Med. 1999;164(9):669-670.
32. Morgenthaler TI, Silber MH. Amnestic sleep-related eating disorder associated with zolpidem. Sleep Med. 2002;3(4):323-327.
33. Sattar SP, Ramaswamy S, Bhatia SC, et al. Somnambulism due to probable interaction of valproic acid and zolpidem. Ann Pharmacother. 2003;37(10):1429-1433.
34. Sharma A, Dewan VK. A case report of Zolpidem-induced somnambulism. Prim Care Companion J Clin Psychiatry. 2005;7(2):74.
35. Sansone RA, Sansone LA. Zolpidem, somnambulism, and nocturnal eating. Gen Hosp Psychiatry. 2008;30(1):90-91.
36. Ganzoni E, Santoni JP, Chevillard V, et al. Zolpidem in insomnia: a 3-year post-marketing surveillance study in Switzerland. J Int Med Res. 1995;23(1):61-73.
37. American Academy of Sleep Medicine. The International Classification of Sleep Disorders: Diagnostic and Coding Manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005
38. Hoque R, Chesson AL Jr. Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. J Clin Sleep Med. 2009;5(5):471-476.
39. Najjar M. Zolpidem and amnestic sleep related eating disorder. J Clin Sleep Med. 2007;3(6):637-638.
40. Yun C-H, Ji K-H. Zolpidem-induced sleep-related eating disorder. J Neurol Sci. 2010;288(1-2):200-201.
41. Vetrugno R, Manconi M, Ferini-Strambi L, et al. Nocturnal eating: sleep-related eating disorder or night eating syndrome? a videopolysomnographic study. Sleep. 2006;29(7):949-954.
42. Tsuji S, Kurata K, Fujikawa T. Sleep-related eating disorder induced by zolpidem. Japanese Journal of Psychiatric Treatment. 2007;22:1169-1172 [in Japanese].
43. Hajak G, Hedner J, Eglin M, et al. Gaboxadol Study 99775 Group. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients. Sleep Med. 2009;10(7):705-712.
44. Aragona M. Abuse, dependence, and epileptic seizures after zolpidem withdrawal: review and case report. Clin Neuropharmacol. 2000;23(5):281-283.
45. Cubala WJ, Landowski J. Seizure following sudden zolpidem withdrawal. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(2):539-540.
46. Victorri-Vigneau C, Dailly E, Veyrac G, et al. Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol. 2007;64(2):198-209.
47. Tsai M-J, Huang Y-B, Wu P-C. A novel clinical pattern of visual hallucination after zolpidem use. J Toxicol Clin Toxicol. 2003;41(6):869-872.